Please Wait...

Clinical Trial Articles

Whether you're interested in the current clinical trial management industry trends or want to know more about the latest FDA requirements, our collection of clinical trial articles will keep you up to date on what's happening now in clinical research news.

Clinical Trial Articles

2017

Essential ToolsCo-authored by Mélanie Bodnar-Wachtel, PhD and Tanja Schubert, PhD

This article is taken from European Biopharmaceutical Review April 2017, pages 34-38. © Samedan Ltd.

2016

Kristin Mauri, PMP, Enterprise Quality Management of Clinical Trials, April 2016.

Clare Jackson, Utku Ozdemir, Liz Moench.  Take a Chance.  ICT.  February 2016.

2014

deVillafranca C, Andrus J. Technology Considerations To Increasing Clinical Trial Efficiencies With Risk-Based Monitoring. Life Science Leader. January 31, 2014.

Lin EH, Lenz HJ, Saleh MN, Mackenzie MJ, Knost JA, Pathiraja K, Langdon RB, Yao S, Lu BD.  A randomized, phase II study of the anti-insulin-like growth factor receptor type 1 (IGF-1R) monoclonal antibody robatumuma

Herron D. The New Road of Cardio-Oncology in Clinical Development. Applied Clinical Trials. April 1, 2014.

2013

Borradaile K, Duffy K, O'Neal M. A Potential New Approach to Assessing PFS in Solid Tumor Studies. International Clinical Trials, May 2013.

O'Neal M, Strafaci J, Scarimbolo R, and Van Heertum R. A Paradigm in Evolution. European Pharmaceutical Contractor (EPC) March 2013.

2012

Yu HJ, Miller CG, Flitcraft D. Metrics in Medical Imaging: Changing the Picture. ACRP: The Monitor. August 2012.

2011

van Meurs P, Miller CG. Image Conscious: New FDA Guidance. Samedan Ltd. 2011 Dec: 24-28.

Spano Lander A and Lander, Reta C Rupich. No Limits: The Evolution of DXA. International Clinical Trials, February, 2011.

2010

Borradaile K, Robert F, O'Neal M, Byrne K.

Webber B.

Ahmad H.

2009

Weinstein M. An Albatross and an Opportunity. View on Clinical Operations. 2009 Jun.

2007

Claypool, B.  Functional outsourcing: a better alternative to traditional outsourcing and EDC. Next Generation Pharmaceutical. 2007.

2006

Reiber J, Heyrich G, van Weert A. A Period of Refinement. European Pharmaceutical Contractor (EPC). 2006;100-102.

2004

Miller CG, Noever K.

van Weert A, Reiber J.

van Weert A and Reiber J.

Kradjian S, Baratelle A, Einstein SG, Kaslow DCDevelopment of a Charter for an Endpoint Assessmen

2003

Miller C, Noever K. Scanning data for clinical information. Good Clinical Practices Journal. 2003. 10;9:21-24.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

"Mud run" 1 obstacle in vaccine trials w elderly. Here R 5 more & how to conquer by Dr. Craig Curtis… https://t.co/vIk4B2Howd
bioclinica (3 hours ago)
What's new in tech for ICH E6 R2 reqs for quality and #RBM? https://t.co/xsmNm8d35o #Pharma
bioclinica (6 hours ago)
Vaccine clinical trials: Boost senior participation following simple advice from Dr. Craig Curtis… https://t.co/OuTKyu0DPT
bioclinica (7 hours ago)
RT @ElisendaGendra: Decision on #EMA Relocation Set for November, Council Agrees on Bidding Procedure via @RAPSorg https://t.co/a42Eszg81o…
bioclinica (Yesterday)
@Xtalks Looking forward to tomorrow's webinar on site payments!
bioclinica (Yesterday)
Conducting Lymphoma ClinicalTrials? Lugano 2014 criteria for assessing FDG-PET/CT. An operational appch https://t.co/x5bdpI8jUI
bioclinica (Yesterday)

Latest Blogs: